T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
SL Green Realty
SLG
$4B
| $18.7M | ﹤0.01% |
553,849
-339,102
| -38% | -$12.9M |
|
927
Nordson
NDSN
$17.3B
| $18.7M | ﹤0.01% |
78,506
+564
| +0.7% | +$129K |
|
928
Rollins
ROL
$17.6B
| $18.6M | ﹤0.01% |
508,461
+11,731
| +2% | +$456K |
|
|
SPNS
929
DELISTED
Sapiens International
SPNS
| $18.6M | ﹤0.01% |
1,004,031
-38,110
| -4% | -$717K |
|
|
GRMN
930
Garmin
GRMN
$59.8B
| $18.4M | ﹤0.01% |
199,841
+1,733
| +0.9% | +$153K |
|
931
Constellium
CSTM
$3.95B
| $18.3M | ﹤0.01% |
1,548,638
-66,091
| -4% | -$772K |
|
932
Biohaven
BHVN
$2.24B
| $18.3M | ﹤0.01% |
+1,316,204
| New | +$18.6M |
|
|
FOLD
933
DELISTED
Amicus Therapeutics
FOLD
| $18.2M | ﹤0.01% |
1,490,195
+31,475
| +2% | +$354K |
|
934
Supernus Pharmaceuticals
SUPN
$2.78B
| $18.2M | ﹤0.01% |
509,353
+1,490
| +0.3% | +$51.8K |
|
935
Alliant Energy
LNT
$18.2B
| $18.1M | ﹤0.01% |
328,058
+1,248
| +0.4% | +$66.6K |
|
936
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.85B
| $18.1M | ﹤0.01% |
+278,700
| New | +$17.2M |
|
937
CarMax
KMX
$8.33B
| $18M | ﹤0.01% |
295,346
-6,185
| -2% | -$397K |
|
938
Williams-Sonoma
WSM
$28.9B
| $17.8M | ﹤0.01% |
310,172
-5,006
| -2% | -$301K |
|
939
A10 Networks
ATEN
$2B
| $17.7M | ﹤0.01% |
1,066,973
+11,959
| +1% | +$205K |
|
|
CPRX
940
DELISTED
Catalyst Pharmaceutical
CPRX
| $17.7M | ﹤0.01% |
950,774
+935,316
| +6,051% | +$14.4M |
|
941
Immuneering
IMRX
$328M
| $17.6M | ﹤0.01% |
3,619,560
-43,932
| -1% | -$389K |
|
942
Akamai
AKAM
$18B
| $17.5M | ﹤0.01% |
207,495
-489
| -0.2% | -$42.6K |
|
|
CINC
943
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $17.5M | ﹤0.01% |
1,423,124
+145,745
| +11% | +$3.47M |
|
944
Teradata
TDC
$2.49B
| $17.4M | ﹤0.01% |
515,620
+6,820
| +1% | +$219K |
|
945
Healthpeak Properties
DOC
$14.2B
| $17.4M | ﹤0.01% |
692,201
+2,973
| +0.4% | +$72.3K |
|
|
PWSC
946
DELISTED
PowerSchool Holdings, Inc.
PWSC
| $17.3M | ﹤0.01% |
+751,511
| New | +$14.7M |
|
947
C4 Therapeutics
CCCC
$502M
| $17.3M | ﹤0.01% |
2,925,253
-38,803
| -1% | -$322K |
|
948
Twist Bioscience
TWST
$7.85B
| $17.2M | ﹤0.01% |
724,252
-86,971
| -11% | -$2.52M |
|
949
Bloomin' Brands
BLMN
$975M
| $17.2M | ﹤0.01% |
856,442
+72,010
| +9% | +$1.56M |
|
950
PUT
Invesco Senior Loan ETF
BKLN
$6.76B
| $17.1M | ﹤0.01% |
831,700
-1,288,000
| -61% | -$26.7M |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.